Wanbury has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Elizabeth Mathew.
Wanbury has received approval for debt settlement and fund raising plan by sale of few brands. The Board of Directors of the Company at its meeting held on September 20, 2019 has approved the same.
Wanbury has received approval for debt settlement and fund raising plan by sale of few brands. The Board of Directors of the Company at its meeting held on June 01, 2019 has approved the same.
Wanbury has informed about dispatch of Postal Ballot Notice.
The above information is a part of company’s filings submitted to BSE....
Wanbury has informed that the Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2018 to September 27, 2018 for the purpose of 30th Annual General Meeting (AGM) of the Compan...
Wanbury is currently trading at Rs. 38.00, down by 0.45 points or 1.17% from its previous closing of Rs. 38.45 on the BSE.
The scrip opened at Rs. 38.00 and has touched a ...
Wanbury has completed the United States Food and Drug Administration (USFDA) inspection at its major API facility in Tanuku Plant, Andhra Pradesh with five observations. The same is being addressed and will be resol...
Wanbury has informed about Postponement of Board Meeting for approving the Un-audited Financial Results of the Company for the second quarter ended September 30, 2016.
The above information is a part of company’s filings submit...
The Exchange has sought clarification from Wanbury on October 24, 2016, with reference to news reported in Economic Times dated October 24, 2016 stating ‘Pharma Co Wanbury Under FDA Scanner’.